HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


‘Change Is Difficult’ But It’s A Must For US FDA's Food Program Culture, Expert Panel Advises

Executive Summary

Expert panel notes overlap between cultural and structural changes, advises changes in both areas should be implemented together. Recommendations for culture changes include “commit to an on-going process of culture change from the highest levels of FDA leadership.”

You may also be interested in...

US FDA’s Human Foods Program Reorganization Plan Isn’t Palatable To Supplement Industry

Reorganization of CFSAN and related ORA operations into “unified Human Foods Program” would move ODSP into Office of Food Chemical Safety, Dietary Supplements and Innovation. Stakeholders plan to influence agency against making the change, or sway lawmakers to object, similar to what they did pushing for ODSP’s establishment less than 10 years ago.

FDA Announces New Home For Cosmetics Under Proposed Food Program Restructuring

The agency plans to move cosmetics regulation and color certification functions out of the Center for Food Safety and Applied Nutrition and into the Office of the Chief Scientist. The Personal Care Products Council and Independent Beauty Association provide their initial reactions.

Supply Chain: A Science Food, Drug And Device Industries And US FDA Should Study – Califf

Topping Califf’s list of getting ready for future is “a vast need at the FDA for integrative data science." In a review he conducted of improvements agency centers are targeting, each listed supply chain information as top concern.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts